Vol.

No.

July 02, 2021Jul 02, 2021

DOWNLOAD THE PDF

Cover Story

Single digits: Black, Hispanic scientists strikingly underrepresented at NCI among senior workforce and grantees

A recent analysis of the National Cancer Institute’s workforce and grant recipients shows that Black and Hispanic scientists are dramatically underrepresented across key metrics, both intramural and extramural.

Free Guest Editorial

The Duma Lab seeks to change how mentorship works for underrepresented women in medicine

By Coral Olazagasti, Carolina Bernabe, Shruti Patel, Idalid Franco, Dame Idossa and Ana I. Velázquez Mañana

Free Obituary

John F. Potter, founder of Georgetown Lombardi Cancer Center, dies at 95

Free In the Archives

The institutions that shaped oncology

In Brief

Quynh-Thu Le named group chair of NRG Oncology

Marcus Bosenberg named inaugural director of Yale Center for Immuno-Oncology

Sarah Tasian named chief of the Section of Hematologic Malignancies at CHOP

AccessHope, Dana-Farber Cancer Institute partner to expand access to specialized cancer treatments

Clinical Roundup

Study sheds light on persistent racial disparities in prostate cancer care in the U.S.

City of Hope-led research identifies how the most common type of breast cancer becomes resistant to treatment

USC cancer neuroscientists identify a key culprit behind pediatric brain cancer’s spread

Drugs & Targets

Rylaze receives FDA approval as component of chemotherapy regimen for leukemia and lymphoma

EC approves Opdivo + Yervoy for adults in dMMR or MSI-H metastatic colorectal cancer indication

EC approves Keytruda + chemo for esophageal cancer or HER2-negative gastroesophageal junction adenocarcinoma

EC approves Libtayo for first-line treatment of advanced NSCLC with ≥50% PD-L1 expression

NCI Trials

NCI Trials for July 2021

The National Cancer Institute approved the following clinical research studies last month. For further information, contact the principal investigator listed.

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues